Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.2.2
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2011
Dec. 31, 2021
Product Liability Contingency [Line Items]            
Royalty received     $ 30,000   $ 1,332  
LIBOR interest rate $ 1,426   $ 1,426     $ 1,419
Royalties on revenues, percentage     4.00%      
Net sales percentage     3.00%      
Licensing percentage     5.00%      
Contingent royalty obligation 1,789   $ 1,789     $ 1,760
Gain loss on change in fair value of contingent royalty obligation $ 34 $ 35   $ 152    
Gain loss on change in fair value of contingent royalty obligation     29 152    
Manufacturing Costs     211      
Severance Costs     1,428      
Royalty [Member]            
Product Liability Contingency [Line Items]            
Royalties income     20,000      
License [Member]            
Product Liability Contingency [Line Items]            
Royalty received     $ 3,500      
Series A Preferred Stock [Member]            
Product Liability Contingency [Line Items]            
Percentage of payment amount     10.00%      
Private Placement [Member]            
Product Liability Contingency [Line Items]            
Net sales percentage     3.00%      
Licensing percentage     5.00%      
Royalty Payment Rights Certificates [Member]            
Product Liability Contingency [Line Items]            
Description of royalty payment     the Royalty Payment Rights initially entitled the holders in aggregate, to a royalty in an amount of      
Israeli National Authority for Technical Innovation [Member]            
Product Liability Contingency [Line Items]            
Royalty received     $ 0 $ 0